PISMATARO, MARIA CHIARA
PISMATARO, MARIA CHIARA
Dipartimento di Scienze Farmaceutiche
Stable desensitization of α7 nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding site
2021 M.C. Pismataro, N.A. Horenstein, C. Stokes, C. Dallanoce, G.A. Thakur, R.L. Papke
Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation
2020 M.C. Pismataro, N.A. Horenstein, C. Stokes, M. Quadri, M. De Amici, R.L. Papke, C. Dallanoce
DESIGN AND SYNTHESIS OF NOVEL MOLECULAR PROBES TARGETING THE ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTORS: INSIGHT INTO THE MECHANISMS OF ACTIVATION AND THE RELATED THERAPEUTIC IMPLICATIONS
2019 M.C. Pismataro
Silent agonism mediated by the α7 nicotinic acetylcholine receptor: the role of trifluoromethyl group in the NS6740 molecular skeleton
2018 M.C. Pismataro, C. Stokes, R.L. Papke, N.A. Horenstein, C. Dallanoce
Alpha7 nicotinic acetylcholine receptor silent agonists: exploration of the SAR for NS6740
2018 M.C. Pismataro, C. Stokes, R.L. Papke, N.A. Horenstein, C.M. Dallanoce
Fragmentation of NS6740 molecular skeleton to investigate the alpha7 nicotinic acetylcholine receptor silent activation
2018 M.C. Pismataro, C. Stokes, R.L. Papke, N.A. Horenstein, C. Dallanoce
Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine-Δ2-Isoxazoline Scaffold : Synthesis and Electrophysiological Evaluation
2017 M. Quadri, C. Matera, A. Silnovic, M.C. Pismataro, N.A. Horenstein, C. Stokes, R.L. Papke, C. Dallanoce
Novel quinuclidine derivatives to investigate the alpha-7 nicotinic acetylcholine receptor activation: new insight and perspectives
2016 M. Quadri, C. Matera, A. Silnovic, M.C. Pismataro, N.A. Horenstein, R.L. Papke, C. Dallanoce